Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1971 1
1972 1
1974 1
1975 1
1976 2
1977 3
1979 6
1981 4
1982 2
1983 4
1984 3
1985 7
1986 5
1987 12
1988 14
1989 11
1990 9
1991 10
1992 12
1993 16
1994 14
1995 9
1996 8
1997 7
1998 15
1999 14
2000 14
2001 13
2002 9
2003 15
2004 13
2005 14
2006 22
2007 15
2008 22
2009 23
2010 17
2011 21
2012 14
2013 21
2014 30
2015 17
2016 26
2017 24
2018 21
2019 25
2020 28
2021 24
2022 29
2023 21
2024 25
2025 28
2026 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

678 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean primary secondary sraynaud (527,125 results)?
Part II: The treatment of primary and secondary Raynaud's phenomenon.
Curtiss P, Svigos K, Schwager Z, Lo Sicco K, Franks AG Jr. Curtiss P, et al. J Am Acad Dermatol. 2024 Feb;90(2):237-248. doi: 10.1016/j.jaad.2022.05.067. Epub 2022 Jul 6. J Am Acad Dermatol. 2024. PMID: 35809802 Review.
Raynaud phenomenon (RP) presents with either primary or secondary disease, and both have the potential to negatively impact patient quality of life. First-line management of RP should include lifestyle modifications in all patients. Some patients with …
Raynaud phenomenon (RP) presents with either primary or secondary disease, and both have the potential to negati …
Calcium channel blockers for primary and secondary Raynaud's phenomenon.
Rirash F, Tingey PC, Harding SE, Maxwell LJ, Tanjong Ghogomu E, Wells GA, Tugwell P, Pope J. Rirash F, et al. Cochrane Database Syst Rev. 2017 Dec 13;12(12):CD000467. doi: 10.1002/14651858.CD000467.pub2. Cochrane Database Syst Rev. 2017. PMID: 29237099 Free PMC article.
Primary Raynaud's phenomenon is not associated with underlying disease, but secondary Raynaud's phenomenon is associated with connective tissue disorders such as systemic sclerosis, systemic lupus erythematosus, and mixed connectiv …
Primary Raynaud's phenomenon is not associated with underlying disease, but secondary Raynaud's …
Raynaud's phenomenon (secondary).
Herrick A, Muir L. Herrick A, et al. BMJ Clin Evid. 2014 Oct 14;2014:1125. BMJ Clin Evid. 2014. PMID: 25322727 Free PMC article.
The classic triphasic colour change is white (ischaemia), then blue (de-oxygenation), then red (reperfusion). Raynaud's phenomenon can be primary (idiopathic) or secondary to several different conditions and causes. ...This review deals with seconda …
The classic triphasic colour change is white (ischaemia), then blue (de-oxygenation), then red (reperfusion). Raynaud's phenom …
Part I: Epidemiology, pathophysiology, and clinical considerations of primary and secondary Raynaud's phenomenon.
Curtiss P, Svigos K, Schwager Z, Lo Sicco K, Franks AG Jr. Curtiss P, et al. J Am Acad Dermatol. 2024 Feb;90(2):223-234. doi: 10.1016/j.jaad.2022.06.1199. Epub 2022 Jul 7. J Am Acad Dermatol. 2024. PMID: 35809798 Review.
Raynaud's phenomenon (RP) is a relatively common disease with both primary and secondary forms. ...It is therefore crucial for dermatologists to distinguish between primary and secondary disease forms early in clinical evalu …
Raynaud's phenomenon (RP) is a relatively common disease with both primary and secondary forms. ...It is …
Botulinum toxin in the management of primary and secondary Raynaud's phenomenon.
Ennis D, Ahmad Z, Anderson MA, Johnson SR. Ennis D, et al. Best Pract Res Clin Rheumatol. 2021 Sep;35(3):101684. doi: 10.1016/j.berh.2021.101684. Epub 2021 May 5. Best Pract Res Clin Rheumatol. 2021. PMID: 33965340 Review.
Raynaud's phenomenon (RP) is common in rheumatic diseases. In the setting of systemic sclerosis (SSc), it can be complicated by digital ischemia that includes ulceration and gangrene. ...In this article, we review effectiveness/efficacy of botulinum toxin injection …
Raynaud's phenomenon (RP) is common in rheumatic diseases. In the setting of systemic sclerosis (SSc), it can be complicated b …
Raynaud's phenomenon.
Haque A, Hughes M. Haque A, et al. Clin Med (Lond). 2020 Nov;20(6):580-587. doi: 10.7861/clinmed.2020-0754. Clin Med (Lond). 2020. PMID: 33199324 Free PMC article.
Raynaud's phenomenon (RP) is a common vasospastic condition which affects ~5% of the general population. The majority of individuals have primary RP; however, Raynaud's can also occur secondary to a broad range of underlying medical condi …
Raynaud's phenomenon (RP) is a common vasospastic condition which affects ~5% of the general population. The majority of indiv …
Raynaud's phenomenon (secondary).
Herrick A. Herrick A. BMJ Clin Evid. 2008 Sep 26;2008:1125. BMJ Clin Evid. 2008. PMID: 19445801 Free PMC article.
The classic triphasic colour change is white (ischaemia), then blue (deoxygenation), then red (reperfusion). Raynaud's phenomenon can be primary (idiopathic) or secondary to several different conditions and causes. This review deals with secondary …
The classic triphasic colour change is white (ischaemia), then blue (deoxygenation), then red (reperfusion). Raynaud's phenome …
Raynaud's phenomenon-an update on diagnosis, classification and management.
Pauling JD, Hughes M, Pope JE. Pauling JD, et al. Clin Rheumatol. 2019 Dec;38(12):3317-3330. doi: 10.1007/s10067-019-04745-5. Epub 2019 Aug 16. Clin Rheumatol. 2019. PMID: 31420815 Review.
Raynaud's phenomenon (RP) is used to describe a symptom complex caused by digital vascular compromise. ...Raynaud's phenomenon causes significant disease-related morbidity in autoimmune rheumatic diseases such as systemic sclerosis....
Raynaud's phenomenon (RP) is used to describe a symptom complex caused by digital vascular compromise. ...Raynaud's …
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis.
Smith V, Herrick AL, Ingegnoli F, Damjanov N, De Angelis R, Denton CP, Distler O, Espejo K, Foeldvari I, Frech T, Garro B, Gutierrez M, Gyger G, Hachulla E, Hesselstrand R, Iagnocco A, Kayser C, Melsens K, Müller-Ladner U, Paolino S, Pizzorni C, Radic M, Riccieri V, Snow M, Stevens W, Sulli A, van Laar JM, Vonk MC, Vanhaecke A, Cutolo M; EULAR Study Group on Microcirculation in Rheumatic Diseases and the Scleroderma Clinical Trials Consortium Group on Capillaroscopy. Smith V, et al. Autoimmun Rev. 2020 Mar;19(3):102458. doi: 10.1016/j.autrev.2020.102458. Epub 2020 Jan 10. Autoimmun Rev. 2020. PMID: 31927087 Free article. Review.
Since its recent incorporation in the 2013 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria for systemic sclerosis together with its assessed role to monitor disease progression, capillaroscopy became a 'mainstream' …
Since its recent incorporation in the 2013 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification …
A systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud's phenomenon.
Curtiss P, Schwager Z, Cobos G, Lo Sicco K, Franks AG Jr. Curtiss P, et al. J Am Acad Dermatol. 2018 Jun;78(6):1110-1118.e3. doi: 10.1016/j.jaad.2018.01.043. Epub 2018 Mar 31. J Am Acad Dermatol. 2018. PMID: 29408338
BACKGROUND: Multiple placebo-controlled trials have assessed locally applied topical nitrate preparations in treating Raynaud's phenomenon (RP). OBJECTIVES: The objective of this meta-analysis was to assess the effects of local topical nitrates in primary and …
BACKGROUND: Multiple placebo-controlled trials have assessed locally applied topical nitrate preparations in treating Raynaud's …
678 results